Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DocGo Inc. Director's Dealing 2023

Dec 19, 2023

33981_dirs_2023-12-18_eb72b0b8-c22f-4068-8acc-424e2d2da6f2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DocGo Inc. (DCGO)
CIK: 0001822359
Period of Report: 2023-12-15

Reporting Person: TRAVERS JAMES M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-15 Common Stock M 23088 Acquired 56034 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-12-15 Restricted Stock Units $ M 23088 Disposed Common Stock (23088) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 391028 Indirect

Footnotes

F1: Reflects 32,946 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on December 12, 2024. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

F2: The Reporting Person and Susan D. Travers are the managers of Travers Holdings LLC and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings LLC. The Reporting Person and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.

F3: These RSUs were granted pursuant to the Plan and vested on December 15, 2023.